Skip to main content
HairCited

Minoxidil per Alopecia femminile

A

Basato su 67 studi (4 meta-analyses, 11 RCTs) con 28,815 partecipanti totali. 53/67 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Effetto: None None

Popolazione: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Effetto: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo Effetto: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Effetto: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Effetto: None None

Key Statistics

111

Studi

37800

Partecipanti

Positive

A

Grado

Referenced Papers

Australian prescriber 2025 2 citazioni
Annals of dermatology 2025
SAGE open medical … 2024 3 citazioni
Drugs 2023 221 citazioni
Anais brasileiros de … 2023 29 citazioni
Journal of cosmetic … 2023 3 citazioni
The Journal of … 2022 170 citazioni
Faculty reviews 2022 44 citazioni
Journal of cosmetic … 2022 7 citazioni
Journal of the … 2021 42 citazioni
American journal of … 2020 127 citazioni
International journal of … 2020 58 citazioni
Indian dermatology online … 2020 31 citazioni
Actas dermo-sifiliograficas 2019 5 citazioni
International journal of … 2018 129 citazioni
Australian journal of … 2018 8 citazioni
JAMA dermatology 2017 121 citazioni
The Cochrane database … 2016 18 citazioni
The Medical clinics … 2015 66 citazioni
World journal of … 2015 62 citazioni
Seminars in cutaneous … 2015 20 citazioni
Clinical obstetrics and … 2015 9 citazioni
Current problems in … 2015 8 citazioni
Skin therapy letter 2014 29 citazioni
Journal of drugs … 2014 26 citazioni
Dermatologic clinics 2013 78 citazioni
International journal of … 2013 61 citazioni
Indian journal of … 2013 16 citazioni
International journal of … 2013
The Cochrane database … 2012 15 citazioni
Skinmed 2012 5 citazioni
The Australasian journal … 2011 44 citazioni
Seminars in cutaneous … 2009 4 citazioni
American family physician 2009
Journal of the … 2008 290 citazioni
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 citazioni
The British journal … 2005 205 citazioni
The journal of … 2003 102 citazioni
Clinical and experimental … 2002 61 citazioni
Therapeutische Umschau. Revue … 2002 4 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

topical:
2-5% solution, twice daily

Limite massimo: 5% topical solution

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

Momento migliore per l'assunzione: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Effetti collaterali segnalati

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interazioni note

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Livello di assunzione massimo tollerabile: 5% topical solution

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Minoxidil help with Alopecia femminile?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia femminile management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia femminile?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia femminile?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.